Back to Search
Start Over
A multifaceted intervention to improve syphilis screening and treatment in pregnant women in Kinshasa, Democratic Republic of the Congo and in Lusaka, Zambia: a cluster randomised controlled trial
- Source :
- The Lancet Global Health, Vol 7, Iss 5, Pp e655-e663 (2019), CONICET Digital (CONICET), Consejo Nacional de Investigaciones Científicas y Técnicas, instacron:CONICET
- Publication Year :
- 2019
- Publisher :
- Elsevier, 2019.
-
Abstract
- Background: Despite international recommendations, coverage of syphilis testing in pregnant women and treatment of those found seropositive remains limited in sub-Saharan Africa. We assessed whether combining the provision of supplies with a behavioural intervention was more effective than providing supplies only, to improve syphilis screening and treatment during antenatal care. Methods: In this 18-month, cluster randomised controlled trial, we randomly assigned (1:1) 26 urban antenatal care clinics in Kinshasa, Democratic Republic of the Congo, and Lusaka, Zambia, to receive a behavioural intervention (opinion leader selection, academic detailing visits, reminders, audits and feedback, and supportive supervision) plus supplies for syphilis testing and treatment (intervention group) or to receive supplies only (control group). The primary outcomes were proportion of pregnant women who had syphilis screening out of the total who attended the clinic; and the proportion of women who had treatment with benzathine benzylpenicillin out of those who tested positive for syphilis at their first antenatal care visit. This trial is registered at ClinicalTrials.gov, number NCT02353117. Findings: The 18-month study period was Feb 1, 2016, to July 14, 2017. 18 357 women were enrolled at the 13 intervention clinics and 17 679 women were enrolled at the 13 control clinics at their first antenatal care visit. Syphilis screening was done in a median of 99·9% (IQR 99·0–100·0) of women in the intervention clinics and 93·8% (85·0–98·9) in the control clinics (absolute difference 6·1% [95% CI 1·1–14·1]; p=0·00092). Syphilis treatment at the first visit was done in a median of 100% (IQR 99·7–100·0) of seropositive women in intervention clinics and 43·2% (2·6–83·2) of seropositive women in control clinics (absolute difference 56·8% [12·8–99·0]; p=0·0028). Interpretation: A behavioural intervention, together with the provision of supplies, can lead to more than 95% of women being screened and treated for syphilis. The sole provision of supplies is sufficient to reach such levels of screening coverage but is not sufficient to ensure high levels of treatment. Funding: Bill & Melinda Gates Foundation. Fil: Althabe, Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto de Efectividad Clínica y Sanitaria; Argentina. Organizacion Mundial de la Salud; Argentina Fil: Chomba, Elwyn. University Teaching Hospital of Lusaka; Zambia Fil: Tshefu, Antoinette K. University of Kinshasa; República Democrática del Congo Fil: Banda, Ernest. University Teaching Hospital of Lusaka; Zambia Fil: Belizán, María Melina Eleonora. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Bergel, Eduardo. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Berrueta, Amanda Mabel. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Bertrand, Jane. University of Tulane; Estados Unidos Fil: Bose, Carl. University of North Carolina; Estados Unidos Fil: Cafferata, Maria Luisa. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Carlo, Waldemar A. University of Alabama at Birmingahm; Estados Unidos Fil: Ciganda, Alvaro. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Donnay, France. University of Tulane; Estados Unidos Fil: Garcia Elorrio, Ezequiel. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Gibbons, Luz. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Klein, Karen. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Liljestrand, Jerker. Bill And Melinda Gates Foundation; Estados Unidos Fil: Lusamba, Paul D. University of Kinshasa; República Democrática del Congo Fil: Mavila, Arlette K. University of Kinshasa; República Democrática del Congo Fil: Mazzoni, Agustina. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Nkamba, Dalau M. University of Kinshasa; República Democrática del Congo Fil: Mwanakalanga, Friday H. University Teaching Hospital Lusaka; Zambia Fil: Mwapule Tembo, Abigail. University Teaching Hospital Lusaka; Zambia Fil: Mwenechanya, Musaku. University Teaching Hospital Lusaka; Zambia Fil: Pyne Mercier, Lee. Bill And Melinda Gates Foundation; Estados Unidos Fil: Spira, Cintia. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Wetshikoy, Jean D. University of Kinshasa; República Democrática del Congo Fil: Xiong, Xu. University of Tulane; Estados Unidos Fil: Buekens, Pierre. University of Tulane; Estados Unidos
- Subjects :
- Benzathine benzylpenicillin
medicine.medical_specialty
Adolescent
030231 tropical medicine
Zambia
law.invention
Academic detailing
Young Adult
03 medical and health sciences
chemistry.chemical_compound
purl.org/becyt/ford/3.3 [https]
0302 clinical medicine
Randomized controlled trial
Pregnancy
law
Intervention (counseling)
medicine
Humans
Mass Screening
030212 general & internal medicine
Cluster randomised controlled trial
Syphilis
Pregnancy Complications, Infectious
Young adult
Child
business.industry
Pregnant women
lcsh:Public aspects of medicine
Prenatal Care
lcsh:RA1-1270
General Medicine
medicine.disease
Quality Improvement
Anti-Bacterial Agents
chemistry
Family medicine
Penicillin G Benzathine
Democratic Republic of the Congo
Female
purl.org/becyt/ford/3 [https]
business
Subjects
Details
- Language :
- English
- Volume :
- 7
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- The Lancet Global Health
- Accession number :
- edsair.doi.dedup.....f5c723d479aecb8ff22ab4502cc7ad97